Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Juni 2017 08:00 ET | Quelle: NASDAQ, Inc.

Nasdaq Holds Second Quarter 2017 Investor Conference Call

NEW YORK, June 27, 2017 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) has scheduled its Second Quarter 2017 results announcement. Who:Nasdaq’s CEO, CFO, and additional members of its management...
27. Juni 2017 08:00 ET | Quelle: Dimension Therapeutics

Dimension Therapeutics Completes Strategic Review and Updates Corporate Priorities

Initial data from Phase 1/2 clinical trial of DTX301, Dimension’s lead AAV8 vector product candidate for OTC deficiency, expected year end 2017 IND filings for GSDIa and Hemophilia A expected in...
27. Juni 2017 08:00 ET | Quelle: MGP Ingredients Inc.

MGP Reaches Agreement to Sell Stake in ICP Joint Venture

ATCHISON, Kan., June 27, 2017 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq:MGPI) announced today that it has entered into a merger agreement with an affiliate of SEACOR Holdings, Inc. and...
27. Juni 2017 08:00 ET | Quelle: Iovance Biotherapeutics, Inc.

Lion Biotechnologies, Inc. Changes Name to Iovance Biotherapeutics, Inc.

Name change reflects company’s focus in advancing the field of immuno-oncology Company to trade on NASDAQ under ticker IOVA at market open on June 28, 2017 SAN CARLOS, Calif., June 27, 2017 (GLOBE...
27. Juni 2017 08:00 ET | Quelle: Qorvo, Inc.

Qorvo® Demystifies 5G RF

GREENSBORO, N.C., June 27, 2017 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, has launched its newest e-book, “5G RF For Dummies®.”...
27. Juni 2017 08:00 ET | Quelle: Agile Therapeutics, Inc.

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®

PRINCETON, N.J., June 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration...
27. Juni 2017 07:34 ET | Quelle: Cancer Genetics, Inc.

Cancer Genetics, Inc. Launches FDA-Approved Universal Companion Diagnostic for Lung Cancer Leveraging Thermo Fisher's Next Generation Sequencing Panel Oncomine Dx Target Test

CGI is one of the first laboratories in the nation to offer the 23 gene testCGI is working with both pharmaceutical partners and clinical cancer centers to drive usage and adoptionEliminates need for...
27. Juni 2017 07:30 ET | Quelle: Pacific Ethanol, Inc.

Pacific Ethanol to Acquire Illinois Corn Processing

SACRAMENTO, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- Pacific Ethanol, Inc. (NASDAQ:PEIX), a leading producer and marketer of low-carbon renewable fuels in the United States, entered into a...
27. Juni 2017 07:30 ET | Quelle: Strongbridge Biopharma plc

Strongbridge Biopharma plc Completes Target Enrollment of 90 Patients in the Phase 3 SONICS Study Evaluating RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome

DUBLIN, Ireland and TREVOSE, Pa., June 27, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
27. Juni 2017 07:30 ET | Quelle: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Launches the Ganaxolone Clinical Program in Patients with Postpartum Depression

Program to Evaluate Intravenous and Oral Ganaxolone in Patients with Severe or Moderate Postpartum Depression RADNOR, Pa., June 27, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc....

Vorherige Seite

Nächste Seite